| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AMGN | Common Stock | Tax liability | -$134K | -579 | -0.9% | $231.89 | 63.6K | May 5, 2023 | Direct | F1, F2 |
| holding | AMGN | Common Stock | 828 | May 5, 2023 | 401K Plan | F3 |
| Id | Content |
|---|---|
| F1 | These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,151 RSUs which will vest on 5/5/2024; 2,656 RSUs which will vest in installments of 1,308 on 4/30/2024 and 1,348 on 4/30/2025; 3,637 RSUs which will vest in two installments of 1,200 on 5/2/2024 and on 5/2/2025, and one installment of 1,237 on 5/2/2026; and 3,559 RSUs which will vest in two installments of 1,174 on 5/2/2025 and 5/2/2026, and 1,211 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. |
| F2 | These shares include 405 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. |
| F3 | These shares are acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing. |